DCF — UNIVERSITY OF TENNESSEE MEDICAL CENT
Enterprise Value: $-2.9B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.9B
Enterprise Value
$-880.2M
PV of Cash Flows
$-2.0B
PV of Terminal Value
$-3.2B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.1B | $-190.2M | -17.0% | $-237.2M | $-215.6M |
| Year 2 | $1.1B | $-184.5M | -16.0% | $-232.9M | $-192.5M |
| Year 3 | $1.2B | $-178.2M | -15.0% | $-228.1M | $-171.4M |
| Year 4 | $1.2B | $-177.5M | -15.0% | $-228.9M | $-156.3M |
| Year 5 | $1.2B | $-179.7M | -14.0% | $-232.6M | $-144.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.9B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.1B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.17627343829096337
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5